Health Care Communiqué Q1 2016

This communiqué discusses the arrival of a new Gleevec generic, independent auditor validations, CMS Part D prescriber enrollment requirements, biosimilars, and the timeline for Q1 CMS due dates.

Please complete the form below to download the PDF

Get Free Widget